Boehringer Ingelheim Vetmedica Japan Begins Distributing Animal Health Products.Tokyo, Japan, July 4, 2006 - (JCN) - Boehringer Ingelheim Vetmedica Japan, a wholly owned subsidiary Wholly Owned Subsidiary A subsidiary whose parent company owns 100% of its common stock. Notes: In other words, the parent company owns the company outright and there are no minority owners. of Nippon Boehringer Ingelheim, began distributing animal health products through its own sales channel on July 1. As an initial step, the company will market two products, a veterinary drug called METACAM METACAM Meloxicam (medication for dogs) and dietary supplement called VIACTAN Plus. METACAM (meloxicam), which was developed by Boheringer Ingelheim, is a new generation non-steroidal anti-inflammatory drug Non-steroidal anti-inflammatory drugs, usually abbreviated to NSAIDs, are drugs with analgesic, antipyretic and anti-inflammatory effects - they reduce pain, fever and inflammation. indicated for pain control and relief for dogs. The dietary supplement VIACTAN Plus, which targets both dogs and cats, contains both essential fatty acids Essential fatty acids Sources of fat in the diet, including omega-3 and omega-6 fatty acids. Mentioned in: Nutritional Supplements like gamma linolenic acid and antioxidants, including vitamin E. Boehringer Ingelheim Vetmedica Japan aims to reinforce its relationship with animal hospitals and respond to their needs in a timely manner. Copyright [c] 2006 Japan Corporate News Network. All rights reserved. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion